Mednet Logo
HomeQuestion

How do you decide between using ropeginterferon alfa-2b and peginterferon alfa-2a in MPN?

2
1 Answers
Mednet Member
Mednet Member
Hematology · Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital

In general, I favor ropeginterferon as it is FDA-approved and allows for less frequent, every 2-week dosing as compared to peginterferon which is used off-label and requires weekly dosing. However, ropeginterferon is not currently approved for ET and in patients where I decide to use interferon in t...

Register or Sign In to see full answer